How long does CBD take to kick in? From 3 min to 5 h

The reference most often cited is a systematic review published in 2018 in Frontiers in Pharmacology. Millar and colleagues screened 792 publications and kept the 24 that reported pharmacokinetic data in humans. Pharmacokinetics follows a molecule through the body, from absorption to blood peak to elimination.

The figure that answers "how long" is Tmax, the time from intake to the highest blood concentration. These studies never measure when an effect is felt. The review also notes that no study has measured the absolute bioavailability of swallowed CBD in humans, meaning the share that actually reaches the blood. The only known value is for smoking, at 31%.

Inhalation is the quickest route. After a cigarette containing 19.2 mg of CBD, the blood peak came 3 minutes after intake. Smoking also burns plant matter and produces toxic compounds, and our article on vaporisation temperatures explains what changes when nothing burns.

Data on oil held under the tongue come mostly from Sativex sprays, applied inside the cheek or under the tongue, with means of 1 hour to 4.6 hours depending on the trial. The technique and its limits are described in our guide to the sublingual method.

Swallowed CBD goes through the liver before it reaches the general circulation, so the peak comes later and lower. In Taylor and colleagues' trial of an oral solution, Tmax was about 4 to 5 hours. The 2018 review lists no human pharmacokinetic data for cosmetics applied to the skin.

CBD is soluble in fat and insoluble in water. In the phase I trial published in 2018 in CNS Drugs, a high-fat meal raised the blood peak 4.85-fold and total exposure 4.2-fold, with Tmax unchanged.

Another trial cited by Millar saw a similar effect with the mouth spray after a meal: exposure rose 5-fold and the peak 3-fold, though here Tmax moved from 1.4 to 4.0 hours. When you compare two days of use, keep the meal conditions the same.

Half-life is the time the blood concentration takes to halve. For CBD it varies widely with the route and with repeated dosing:

• 1.4 to 10.9 hours after a single dose of mouth spray.
• 2 to 5 days after repeated oral doses, according to an older six-week study.
• About 60 hours of terminal half-life, and 10 to 17 hours of "effective" half-life, for the oral solution taken twice a day in the 2018 trial.

In that trial, steady state (the point where blood levels stop rising from one dose to the next) came after about 2 days of morning and evening doses. CBD then accumulated moderately, by a factor of 1.8 to 2.6. The doses tested were 750 and 1,500 mg, far above those of a shop oil, so only the order of magnitude carries over.

Many brands tell you to wait four to six weeks before judging a product. Neither the ANSM nor the HAS, France's medicines and health technology agencies, issued that benchmark. Pharmacokinetics does not call for it either, since blood levels settle within a few days. The long period mostly evens out day-to-day swings in subjective measures, such as how rested you feel.

For a fair picture, fix the conditions before you begin:

1. Use one product by one route, for example a CBD oil taken the same way every time.
2. Keep the dose and the time of day stable, with the same meal conditions.
3. Write a few lines each day: time, amount, what you notice in the hours that follow, and a score from 1 to 10 the next day.
4. Change nothing else meanwhile, so no new supplement and no shift in your sleep schedule.

The period can end in one of three ways. You may see a clear trend that repeats. You may see no difference, which is a valid answer. Or side effects such as drowsiness or digestive upset may keep coming back, and that is a reason to stop. Self-assessment has a known limit: it cannot tell the product's effect apart from the placebo effect or the ritual. Doubling the dose to "feel something" mostly increases the risk of side effects.

Many people feel nothing, and that is normal. The actual dose may be low, the route inefficient or the product weaker than its label says. Check the batch's certificate of analysis; our laboratory page explains how to read one. Our article on why you might feel nothing with CBD works through these possibilities, and the one on EFSA's reference dose gives benchmarks for quantity.

The French drug policy agency MILDECA reminds sellers that no CBD product sold in shops may claim a therapeutic effect, on pain of criminal penalties. Epidyolex, prescribed for rare epilepsies, is the only authorised medicine based on cannabidiol.

CBD meant to be swallowed comes under the EU novel food regulation. The French Ministry of Agriculture, in a notice published on 20 May 2026, states that foods and food supplements containing CBD are not authorised and announces checks. The full picture is in our overview of CBD regulation in 2026.

EFSA set on 9 February 2026 a provisional safe intake of 0.0275 mg per kilo per day, about 2 mg for an adult of 70 kg. Safety, it adds, is not established under the age of 25, during pregnancy or breastfeeding, or for people on medication. On 21 March 2025, Anses, France's food safety agency, also proposed to classify CBD as presumed toxic for reproduction. If you take any medicine, talk to your doctor. Like many drugs, CBD is processed by the liver enzymes CYP3A4 and CYP2C19, as our article on CBD drug interactions describes.